Dr. Dan Iosifescu, MD, MSc
Claim this profileNYU Langone Health
Affiliated Hospitals
NYU Langone Health
Nathan Kline Institute
Clinical Trials Dan Iosifescu, MD, MSc is currently running
SGLT2 Inhibitor
for Depression
This trial is testing whether empagliflozin, a medication that helps produce ketone bodies, can reduce depression symptoms. It targets people with depression by providing an alternative energy source for the brain, potentially improving their mood.
Recruiting
1 award
Phase 2
3 criteria
Transcranial Photobiomodulation
for Depression
This trial is testing a special kind of invisible light aimed at the forehead to help people with depression. The light might improve blood flow in the brain. About 60 people with depression will be part of this study to see if this treatment works.
Recruiting
1 award
N/A
3 criteria
More about Dan Iosifescu, MD, MSc
Clinical Trial Related
4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Dan Iosifescu, MD, MSc has experience with
- Sham
- Transcranial Photobiomodulator
- Empagliflozin
- Transcranial Photobiomodulator
- Transcranial Photobiomodulation
- Aripiprazole
Breakdown of trials Dan Iosifescu, MD, MSc has run
Depression
Major Depressive Disorder
Cognitive Impairment
Mild Cognitive Impairment
Alzheimer's Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Dan Iosifescu, MD, MSc specialize in?
Dan Iosifescu, MD, MSc focuses on Depression and Major Depressive Disorder. In particular, much of their work with Depression has involved treating patients, or patients who are undergoing treatment.
Is Dan Iosifescu, MD, MSc currently recruiting for clinical trials?
Yes, Dan Iosifescu, MD, MSc is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Dan Iosifescu, MD, MSc has studied deeply?
Yes, Dan Iosifescu, MD, MSc has studied treatments such as Sham, Transcranial Photobiomodulator, Empagliflozin.
What is the best way to schedule an appointment with Dan Iosifescu, MD, MSc?
Apply for one of the trials that Dan Iosifescu, MD, MSc is conducting.
What is the office address of Dan Iosifescu, MD, MSc?
The office of Dan Iosifescu, MD, MSc is located at: NYU Langone Health, New York, New York 10016 United States. This is the address for their practice at the NYU Langone Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.